Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zihua Wenfei granules for postinfectious cough
ChiCTR2300068662Phase 3Recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of Zihua Wenfei Zhisou Granule in postinfectious cough (2 arms), sponsored by West China Hospital of Sichuan University. Primary endpoint: Cough relief rate. Started Nov 2022; status: recruiting.
02
Drugs
Zihua Wenfei Zhisou Granule
03
Conditions
postinfectious cough
Beyond the preview
Go deeper on ChiCTR2300068662.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300068662.